Atlas Trials

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

Clinical trial NCT06341907 · RECRUITING

Trial details

NCT number
NCT06341907
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Epithelial Ovarian Cancer
Start date
2024-01-01
Primary completion
2026-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.